These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3524419)

  • 1. Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli.
    Sheftel TG; Mader JT
    Antimicrob Agents Chemother; 1986 Jan; 29(1):112-5. PubMed ID: 3524419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
    Cone LA; Woodard DR; Stoltzman DS; Byrd RG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R; Overmeyer A; Knie B; Fleming PC; Levison H
    Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS; Cocchetto DM
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia.
    Rapp RP; Young B; Foster TS; Tibbs PA; O'Neal W
    Pharmacotherapy; 1984; 4(4):211-5. PubMed ID: 6384945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
    Reilly JT; Brada M; Bellingham AJ; Hart CA; Bennet C
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():89-92. PubMed ID: 6352660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost comparison of ceftazidime versus tobramycin/ticarcillin therapy in three hospitals.
    Parr MD; Hansen LA; Rapp RP
    Drug Intell Clin Pharm; 1988; 22(7-8):628-31. PubMed ID: 3046892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of skin, skin structure, bone, and joint infections with ceftazidime.
    Gentry LO
    Am J Med; 1985 Aug; 79(2A):67-74. PubMed ID: 3895921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.
    Klastersky J; Hensgens C; Debusscher L
    Antimicrob Agents Chemother; 1975 May; 7(5):640-5. PubMed ID: 1096809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticarcillin plus clavulanic acid (Timentin) therapy for osteomyelitis.
    Gentry LO; Macko V; Lind R; Heilman A
    Am J Med; 1985 Nov; 79(5B):116-21. PubMed ID: 4073077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.
    Mandell LA; Nicolle LE; Ronald AR; Landis SJ; Duperval R; Harding GK; Robson HG; Feld R; Vincelette J; Fong I
    J Antimicrob Chemother; 1987 Jul; 20(1):95-107. PubMed ID: 3305464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis.
    Bach MC; Cocchetto DM
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1605-8. PubMed ID: 3124734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
    Kljucar S; Heimesaat M; von Pritzbuer E; Olms K
    Infection; 1987; 15 Suppl 4():S185-91. PubMed ID: 3312032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
    Parry MF; Neu HC
    Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of the combination of Timentin and tobramycin in the treatment of patients with bacteraemia.
    Degener JE; Wagenvoort JH; Dzoljic-Danilovic G; Michel MF; Brus-Weijer A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():141-8. PubMed ID: 3636329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
    Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
    J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timentin in combination with tobramycin as empirical therapy in febrile neutropenic patients with haematological malignancies.
    Krieger O; Bernhart M; Plohowich R; Nemec H; Lutz D
    J Antimicrob Chemother; 1986 May; 17 Suppl C():211-7. PubMed ID: 3636336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
    J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.